Cargando…

Reclassification of the Fuhrman grading system in renal cell carcinoma-does it make a difference?

PURPOSE: The aim of this study was to determine whether reclassifying the Fuhrman grading system provides further prognostic information. MATERIALS AND METHODS: We studied the pathological features and cancer specific survival of 237 patients with clear cell cancer undergoing surgery between 1997–20...

Descripción completa

Detalles Bibliográficos
Autores principales: Qayyum, Tahir, McArdle, Peter, Orange, Clare, Seywright, Morag, Horgan, Paul, Oades, Grenville, Aitchison, Michael, Edwards, Joanne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3755806/
https://www.ncbi.nlm.nih.gov/pubmed/24010036
http://dx.doi.org/10.1186/2193-1801-2-378
_version_ 1782282003459080192
author Qayyum, Tahir
McArdle, Peter
Orange, Clare
Seywright, Morag
Horgan, Paul
Oades, Grenville
Aitchison, Michael
Edwards, Joanne
author_facet Qayyum, Tahir
McArdle, Peter
Orange, Clare
Seywright, Morag
Horgan, Paul
Oades, Grenville
Aitchison, Michael
Edwards, Joanne
author_sort Qayyum, Tahir
collection PubMed
description PURPOSE: The aim of this study was to determine whether reclassifying the Fuhrman grading system provides further prognostic information. MATERIALS AND METHODS: We studied the pathological features and cancer specific survival of 237 patients with clear cell cancer undergoing surgery between 1997–2007 in a single centre. The original Fuhrman grading system was investigated as well as various simplified models utilising the original Fuhrman grade. RESULTS: The median follow up was 69 months. On univariate analysis, the conventional Fuhrman grading system as well various simplified models were predicative of cancer specific survival. On multivariate analysis, only the three tiered modified model in which grades 1 and 2 were combined whilst grades 3 and 4 were kept separate was an independent predictor of cancer specific survival (p=0.001, HR 2.17, 95% CI 1.37-3.43). Furthermore this simplified model demonstrated a stronger relationship to recurrence than the conventional 4 tiered Fuhrman grading system. CONCLUSIONS: A modified, three-tiered Fuhrman grading system has been demonstrated to be an independent predictor of cancer specific survival.
format Online
Article
Text
id pubmed-3755806
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-37558062013-09-04 Reclassification of the Fuhrman grading system in renal cell carcinoma-does it make a difference? Qayyum, Tahir McArdle, Peter Orange, Clare Seywright, Morag Horgan, Paul Oades, Grenville Aitchison, Michael Edwards, Joanne Springerplus Research PURPOSE: The aim of this study was to determine whether reclassifying the Fuhrman grading system provides further prognostic information. MATERIALS AND METHODS: We studied the pathological features and cancer specific survival of 237 patients with clear cell cancer undergoing surgery between 1997–2007 in a single centre. The original Fuhrman grading system was investigated as well as various simplified models utilising the original Fuhrman grade. RESULTS: The median follow up was 69 months. On univariate analysis, the conventional Fuhrman grading system as well various simplified models were predicative of cancer specific survival. On multivariate analysis, only the three tiered modified model in which grades 1 and 2 were combined whilst grades 3 and 4 were kept separate was an independent predictor of cancer specific survival (p=0.001, HR 2.17, 95% CI 1.37-3.43). Furthermore this simplified model demonstrated a stronger relationship to recurrence than the conventional 4 tiered Fuhrman grading system. CONCLUSIONS: A modified, three-tiered Fuhrman grading system has been demonstrated to be an independent predictor of cancer specific survival. Springer International Publishing 2013-08-10 /pmc/articles/PMC3755806/ /pubmed/24010036 http://dx.doi.org/10.1186/2193-1801-2-378 Text en © Qayyum et al.; licensee Springer. 2013 This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Qayyum, Tahir
McArdle, Peter
Orange, Clare
Seywright, Morag
Horgan, Paul
Oades, Grenville
Aitchison, Michael
Edwards, Joanne
Reclassification of the Fuhrman grading system in renal cell carcinoma-does it make a difference?
title Reclassification of the Fuhrman grading system in renal cell carcinoma-does it make a difference?
title_full Reclassification of the Fuhrman grading system in renal cell carcinoma-does it make a difference?
title_fullStr Reclassification of the Fuhrman grading system in renal cell carcinoma-does it make a difference?
title_full_unstemmed Reclassification of the Fuhrman grading system in renal cell carcinoma-does it make a difference?
title_short Reclassification of the Fuhrman grading system in renal cell carcinoma-does it make a difference?
title_sort reclassification of the fuhrman grading system in renal cell carcinoma-does it make a difference?
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3755806/
https://www.ncbi.nlm.nih.gov/pubmed/24010036
http://dx.doi.org/10.1186/2193-1801-2-378
work_keys_str_mv AT qayyumtahir reclassificationofthefuhrmangradingsysteminrenalcellcarcinomadoesitmakeadifference
AT mcardlepeter reclassificationofthefuhrmangradingsysteminrenalcellcarcinomadoesitmakeadifference
AT orangeclare reclassificationofthefuhrmangradingsysteminrenalcellcarcinomadoesitmakeadifference
AT seywrightmorag reclassificationofthefuhrmangradingsysteminrenalcellcarcinomadoesitmakeadifference
AT horganpaul reclassificationofthefuhrmangradingsysteminrenalcellcarcinomadoesitmakeadifference
AT oadesgrenville reclassificationofthefuhrmangradingsysteminrenalcellcarcinomadoesitmakeadifference
AT aitchisonmichael reclassificationofthefuhrmangradingsysteminrenalcellcarcinomadoesitmakeadifference
AT edwardsjoanne reclassificationofthefuhrmangradingsysteminrenalcellcarcinomadoesitmakeadifference